Milpharm Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Milpharm Ltd - overview
Location
Ruislip, England, UK
Primary Industry
Pharmaceuticals
About
Based in the UK, Milpharm Ltd operates as a manufacturer of pharmaceutical products.
Current Investors
Aurobindo Pharma Ltd.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Milpharm Ltd - timeline of key events
Milpharm Ltd - financials
| Fiscal Year Ended | Mar 31, 2010 | Mar 31, 2011 | Mar 31, 2012 | Mar 31, 2013 | Mar 31, 2014 | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 9,611,323 | 11,614,131 | 10,478,736 | 13,229,234 | 18,522,930 | 21,650,559 | 24,144,911 | 30,537,709 | 59,562,624 | 59,618,527 | 64,809,436 | 77,568,089 | 57,495,344 | - | - | - |
| % Revenue Growth (YoY) | - | 20.8% | (9.8%) | 26.2% | 40.0% | 16.9% | 11.5% | 26.5% | 95.0% | 0.1% | 8.7% | 19.7% | (25.9%) | - | - | - |
| EBITDA (USD) | 680,969 | 1,220,303 | 800,076 | 2,053,099 | 2,377,626 | 634,488 | 2,384,939 | 2,047,403 | 3,686,343 | 3,828,990 | 5,200,385 | 7,107,453 | 4,421,549 | - | - | - |
| Operating Income (USD) | 311,626 | 854,634 | 433,265 | 802,447 | 1,777,286 | 118,767 | 1,650,443 | 1,334,539 | 2,913,941 | 3,155,182 | 4,541,994 | 6,490,661 | 3,920,036 | - | - | - |
| Operating Margin | 3.2% | 7.4% | 4.1% | 6.1% | 9.6% | 0.5% | 6.8% | 4.4% | 4.9% | 5.3% | 7.0% | 8.4% | 6.8% | - | - | - |
| % EBITDA Margin | 7.1% | 10.5% | 7.6% | 15.5% | 12.8% | 2.9% | 9.9% | 6.7% | 6.2% | 6.4% | 8.0% | 9.2% | 7.7% | - | - | - |
| NET Income (USD) | 328,163 | 760,333 | 284,279 | 594,686 | 1,330,261 | 95,403 | 1,251,584 | 997,379 | 2,300,733 | 2,536,959 | 3,664,065 | 5,255,431 | 3,172,877 | - | - | - |
| % Net Margin | 3.4% | 6.5% | 2.7% | 4.5% | 7.2% | 0.4% | 5.2% | 3.3% | 3.9% | 4.3% | 5.7% | 6.8% | 5.5% | - | - | - |
Milpharm Ltd - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Milpharm Ltd | - |
Displaying 1 - 1 of 1
Milpharm Ltd - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.